News
3 Options to Meet USP 797 Requirements for Combination Ophthalmic Dilating Drops The following article is written by Brian Williamson, PharmD, president & CEO of JCB Laboratories. Dilating patients’ ...
The latest BUD guidance outlined in USP <797> introduced a new categorization system (Categories 1, 2, and 3), replacing the previous low, medium, and high-risk classifications.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback